The global anti-fibrotic therapy for ocular fibrosis market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Fibrosis and scarring are involved in the pathogenesis or failure of treatment of virtually all the major blinding diseases. Congenital fibrosis of the extraocular muscles (CFEOM) is a disorder of the nervous system that affects the use of the muscles that surround the eyes, also known as extraocular muscles. These muscles support managing eye movement and the direction of the eyes. CFEOM impairs control of these muscles. Antifibrotic agents are widely used during combined cataract and glaucoma surgery.

The major factor that is fuelling the growth of the global Anti-Fibrotic Therapy for Ocular Fibrosis Market includes the rising geriatric population in various countries. Moreover, rising ocular diseases in emerging countries are expected to amplify the demand for anti-fibrotic therapy for the ocular fibrosis market during the forecast period. The market analysis includes some of the key market players such as Roche, Aspen Pharmacare, Baxter, Novartis, GlaxoSmithKline plc, Bayer, Sun Pharmaceutical, and Cipla, among others. To maintain a strong position in the market, these market players are adopting various strategic moves, such as product launches, partnerships, collaborations, and mergers and acquisitions. 

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: F. Hoffman La-Roche AG, Novartis International AG, and Bayer AG, among others. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Anti-Fibrotic Therapy for Ocular Fibrosis Market Report Segmentation

By Type

• Injection

• Oral

Application

• Hospital

• Eye Clinic

Global Anti-Fibrotic Therapy for Ocular Fibrosis Market by Region